COMPANY

Cogentis Therapeutics Inc.

HQ: Columbia, MD source · cogentistherapeutics.com ↗ · Mid-Atlantic

Keywords: neurology neurodegenerative diseases

Location: Columbia, MD · source · Oct 15, 2026

Profile checked Oct 10, 2026

NIH awards 4

Annual award amounts. Total $2.9M.

Aug 30, 2022 NIH award 5R44NS124471-02 FY2022: $1,027,314 awarded for that fiscal year; activity R44 (SBIR); PI WERNER, JOHN KENT; recipient as written: COGENTIS THERAPEUTICS, INC., Columbia, MD. Development of a Synthetic, Cell- source ↗
Sep 18, 2021 NIH award 1R44NS124471-01A1 FY2021: $1,183,364 awarded for that fiscal year; activity R44 (SBIR); PI WERNER, JOHN KENT; recipient as written: COGENTIS THERAPEUTICS, INC., Columbia, MD. Development of a Synthetic, Cel source ↗
Apr 10, 2020 NIH award 3R43AG062058-01S1 FY2020: $236,325 awarded for that fiscal year; activity R43 (SBIR); PI WERNER, JOHN KENT; recipient as written: COGENTIS THERAPEUTICS, INC., Columbia, MD. Development of CDK5-p25 modulator source ↗
Sep 21, 2018 NIH award 1R43AG062058-01 FY2018: $497,121 awarded for that fiscal year; activity R43 (SBIR); PI WERNER, JOHN KENT; recipient as written: COGENTIS THERAPEUTICS, INC., Columbia, MD. Development of CDK5-p25 modulator t source ↗